New Zealand's buying of millions of doses of flu medicine and swine flu vaccinations has been place in the question box by European reports, which are of the suggestion that pandemic advice was driven by drug corporation interests.

A British Medical Journal investigation has been able to find that key scientists advising the World Health Organization on planning for a flu plague had done work for drug firms, who eventually received benefits from the supervision of the scientist.

WHO's recommendation led to Governments worldwide storing of billions of dollars of antiviral drugs for example Tamiflu before and during the fresh swine flu epidemic. On the other hand, WHO has strongly shunned that it was commercial interests that played a part in its advice.

In the year 2005, the New Zealand Government started hoarding almost 1.2 million doses of Tamiflu for use in a worldwide influenza epidemic.

Merely 20,000 courses have been used and 60,000 dispersed to district health boards.

Almost immediately after the swine flu H1N1 virus arrived in New Zealand in early 2009, the Government purchased 235,000 courses of Relenza, a new antiviral.

The Government also purchased 300,000 doses of a monovalent, single strain, swine flu vaccine.

As of the previous month, no less than 900,000 doses of the seasonal flu vaccine, which comprises of the H1N1 strain had been dispersed all over the country, almost as many doses as were dispersed in the total 2009 flu season.